The effect of inflammatory cell-derived MCP-1 loss on neuronal survival during chronic neuroinflammation

Biomaterials. 2014 Aug;35(25):6698-706. doi: 10.1016/j.biomaterials.2014.05.008. Epub 2014 May 29.

Abstract

Intracranial implants elicit neurodegeneration via the foreign body response (FBR) that includes BBB leakage, macrophage/microglia accumulation, and reactive astrogliosis, in addition to neuronal degradation that limit their useful lifespan. Previously, monocyte chemoattractant protein 1 (MCP-1, also CCL2), which plays an important role in monocyte recruitment and propagation of inflammation, was shown to be critical for various aspects of the FBR in a tissue-specific manner. However, participation of MCP-1 in the brain FBR has not been evaluated. Here we examined the FBR to intracortical silicon implants in MCP-1 KO mice at 1, 2, and 8 weeks after implantation. MCP-1 KO mice had a diminished FBR compared to WT mice, characterized by reductions in BBB leakage, macrophage/microglia accumulation, and astrogliosis, and an increased neuronal density. Moreover, pharmacological inhibition of MCP-1 in implant-bearing WT mice maintained the increased neuronal density. To elucidate the relative contribution of microglia and macrophages, bone marrow chimeras were generated between MCP-1 KO and WT mice. Increased neuronal density was observed only in MCP-1 knockout mice transplanted with MCP-1 knockout marrow, which indicates that resident cells in the brain are major contributors. We hypothesized that these improvements are the result of a phenotypic switch of the macrophages/microglia polarization state, which we confirmed using PCR for common activation markers. Our observations suggest that MCP-1 influences neuronal loss, which is integral to the progression of neurological disorders like Alzheimer's and Parkinson disease, via BBB leakage and macrophage polarization.

Keywords: Foreign body response; MCP-1; Microglia polarization; Neurodegeneration.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Benzoxazines / pharmacology
  • Blood-Brain Barrier / metabolism
  • Brain / metabolism
  • Cell Survival / drug effects
  • Chemokine CCL2 / metabolism*
  • Chronic Disease
  • Foreign-Body Reaction / therapy*
  • Macrophages / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Microglia / metabolism
  • Neurodegenerative Diseases / therapy*
  • Neurons / metabolism*
  • Piperidines / pharmacology
  • Prostheses and Implants
  • Receptors, CCR2 / antagonists & inhibitors
  • Receptors, CCR2 / metabolism
  • Tissue Engineering

Substances

  • Benzoxazines
  • Ccl2 protein, mouse
  • Ccr2 protein, mouse
  • Chemokine CCL2
  • Piperidines
  • RS 102895
  • Receptors, CCR2